Connection

Michael von Bergwelt-Baildon to CD40 Antigens

This is a "connection" page, showing publications Michael von Bergwelt-Baildon has written about CD40 Antigens.
Connection Strength

1.357
  1. Using Antigen-Specific B Cells to Combine Antibody and T Cell-Based Cancer Immunotherapy. Cancer Immunol Res. 2017 09; 5(9):730-743.
    View in: PubMed
    Score: 0.663
  2. The properties of human CD40-activated B cells as antigen-presenting cells are not affected by PGE2. Oncol Rep. 2013 Mar; 29(3):1061-5.
    View in: PubMed
    Score: 0.482
  3. Complex interactions between B cells and dendritic cells. Blood. 2013 Mar 21; 121(12):2367-8.
    View in: PubMed
    Score: 0.122
  4. Statins inhibit human APC function: implications for the treatment of GVHD. Blood. 2008 Aug 15; 112(4):1544-5.
    View in: PubMed
    Score: 0.089
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.